Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
22 hedge funds and large institutions have $654K invested in Guardion Health Sciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
10% more funds holding
Funds holding: 20 → 22 (+2)
40% less capital invested
Capital invested by funds: $1.09M → $654K (-$436K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$64K |
| 2 |
Barclays
London,
United Kingdom
|
+$43.7K |
| 3 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$5.24K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.64K |
| 5 |
SG
StoneX Group
New York
|
+$2.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$114K |
| 2 |
Jane Street
New York
|
-$20K |
| 3 |
BlackRock
New York
|
-$10.3K |
| 4 |
HF
HRT Financial
New York
|
-$9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.65K |
GHSI Hedge Fund Activity: Q2 2022 in Review
22 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q2 2022, worth a combined $654K — down 40% from $1.09M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GHSI positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $64K. The largest seller was Renaissance Technologies, cutting an estimated $114K.
- 22 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q2 2022, up from 20 in Q1 2022.
- Funds reported $654K of Guardion Health Sciences, Inc. Common Stock stock for Q2 2022, down 40% quarter-over-quarter.
- 5 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of +2 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q2 2022 was Millennium Management, an estimated $64K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q2 2022 was Renaissance Technologies, an estimated $114K sold.
Based on aggregated 13F filings for Q2 2022.